Analyst
Individual Investor
Equibles does not estimate personal net worth.
Rajat Srivastala is recorded as Analyst at Individual Investor. Rajat Srivastala has spoken on 1 earnings call across 1 company, most recently for Natco Pharma Limited on November 13, 2026. The companies whose calls Rajat Srivastala spoke on are classified in the Healthcare sector.
“In the cash flow statement, I can see that there is some 300 crore CAPEX already done in the first half, which looks quite high if I compare it to last year. Can you tell us where is this CAPEX going and if you could just share the CAPEX guidance for full year?”
Individual Investor
Analyst
Transcript header (unverified)
Natco Pharma Limited
Drug Manufacturers - Specialty & Generic · Healthcare
Earnings Call for the Quarter Ended September 30, 2026
Natco Pharma Limited
